Alpine Woods Capital Investors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Alpine Woods Capital Investors's VRTX Position: Q2 2026 in Review
Alpine Woods Capital Investors reduced its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q2 2026, selling an estimated $7.53K and leaving 699 shares worth $347K. The position accounts for 0.08% of the portfolio, ranked #149.
Alpine Woods Capital Investors first reported a position in VRTX in Q3 2020 and has held it in 24 quarters since. The position peaked at $3.03M in Q4 2023. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Alpine Woods Capital Investors held 699 shares of Vertex Pharmaceuticals worth $347K as of Q2 2026.
- Alpine Woods Capital Investors sold 17 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.53K.
- Vertex Pharmaceuticals made up 0.08% of Alpine Woods Capital Investors's portfolio in Q2 2026, its #149 holding.
- Alpine Woods Capital Investors first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
- Alpine Woods Capital Investors's Vertex Pharmaceuticals position peaked at $3.03M in Q4 2023.
- 1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.